company background image
SNN logo

Smith & Nephew NYSE:SNN Stock Report

Last Price

US$24.67

Market Cap

US$10.8b

7D

-2.8%

1Y

-11.4%

Updated

07 Feb, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Smith & Nephew plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Smith & Nephew
Historical stock prices
Current Share PriceUK£24.67
52 Week HighUK£31.72
52 Week LowUK£23.65
Beta0.69
1 Month Change1.44%
3 Month Change1.56%
1 Year Change-11.39%
3 Year Change-24.42%
5 Year Change-48.48%
Change since IPO199.03%

Recent News & Updates

Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?

Jan 29

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Nov 10

Recent updates

Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?

Jan 29

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Nov 10

Smith & Nephew Delivering On Its Turnaround Promise

Aug 22

Smith & Nephew: Work To Be Done But Still Long-Term Potential

Jun 12

Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward

Dec 28

Smith & Nephew Getting More Interesting As A Contrarian Idea

Oct 12

Smith & Nephew: Entering New Markets But Growth Is Slow Still

Aug 01

Smith & Nephew reports FY earnings; initiates FY23 guidance

Feb 21

Smith & Nephew: Potential Only Has Value If You Can Execute

Dec 14

Smith & Nephew: Still A Buy Despite Short-Term Challenges

Sep 26

Smith & Nephew 1H 2022 Earnings Preview

Jul 27

Smith+Nephew launches app Wound Compass to help reduce variation in wound care

Jul 12

Smith & Nephew: Fair Price For An Attractive Medical Devices Supplier

Jun 01

Smith & Nephew: Valuation Looking More Attractive

Jan 26

Smith & Nephew Is A Premium Brand That Should Deliver Something Special

Nov 06

Smith & Nephew Leveraged To Post-Pandemic Normalization And Self-Help

Sep 02

Smith & Nephew plc: Improving Performance Reflected In Price

Jun 18

Smith & Nephew: Pandemic Long Tail Reduces Attractiveness

Jan 14

Smith & Nephew: A Long-Term Buy And Hold In Medical Devices

Nov 09

Shareholder Returns

SNNUS Medical EquipmentUS Market
7D-2.8%-0.9%0.2%
1Y-11.4%12.5%22.0%

Return vs Industry: SNN underperformed the US Medical Equipment industry which returned 12.5% over the past year.

Return vs Market: SNN underperformed the US Market which returned 22% over the past year.

Price Volatility

Is SNN's price volatile compared to industry and market?
SNN volatility
SNN Average Weekly Movement2.7%
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.1%
10% most volatile stocks in US Market18.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: SNN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SNN's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
185618,000Deepak Nathwww.smith-nephew.com

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Smith & Nephew plc Fundamentals Summary

How do Smith & Nephew's earnings and revenue compare to its market cap?
SNN fundamental statistics
Market capUS$10.82b
Earnings (TTM)US$305.00m
Revenue (TTM)US$5.64b

35.5x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SNN income statement (TTM)
RevenueUS$5.64b
Cost of RevenueUS$1.67b
Gross ProfitUS$3.97b
Other ExpensesUS$3.66b
EarningsUS$305.00m

Last Reported Earnings

Jun 29, 2024

Next Earnings Date

Feb 25, 2025

Earnings per share (EPS)0.35
Gross Margin70.33%
Net Profit Margin5.41%
Debt/Equity Ratio66.7%

How did SNN perform over the long term?

See historical performance and comparison

Dividends

3.0%

Current Dividend Yield

107%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 23:02
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Smith & Nephew plc is covered by 56 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christoph GublerBank Vontobel AG
Hassan Al-WakeelBarclays
Sally TaylorBarclays